Company Filing History:
Years Active: 1994-1995
Title: A H Davidson: Innovator in Collagenase Inhibition
Introduction
A H Davidson is a notable inventor based in Witney, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit collagenase activity. With a total of 2 patents to his name, Davidson's work is crucial in addressing diseases related to collagen degradation.
Latest Patents
Davidson's latest patents focus on P2'-modified hydroxamic acid collagenase inhibitors. These compounds, represented by a general formula, exhibit collagenase inhibition activity. They are particularly useful in managing diseases such as rheumatoid arthritis, corneal ulceration, osteoporosis, periodontitis, gingivitis, and tumor invasion. The specific variables in the compounds, denoted as R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6, allow for a range of applications in medical treatments.
Career Highlights
Davidson is associated with British Biotechnology Limited, where he continues to innovate in the field of biochemistry. His work has the potential to significantly impact the treatment of various diseases that involve collagen degradation.
Collaborations
Some of Davidson's notable coworkers include M J Crimmin and R P Beckett. Their collaborative efforts contribute to the advancement of research and development in their field.
Conclusion
A H Davidson's contributions to collagenase inhibition represent a significant advancement in medical science. His innovative work continues to pave the way for new treatments for diseases involving collagen degradation.